BioCentury
ARTICLE | Clinical News

MEM 1414: Phase Ib data

May 26, 2008 7:00 AM UTC

In a double-blind, placebo-controlled, French Phase lb trial in 12 healthy volunteers, the two higher doses of MEM 1414 (500 and 750 mg) significantly increased quantitative EEG, a biomarker of CNS ac...